Table 2.
Oncomine analysis of APOC1 expression in colorectal cancer (total 7 colorectal cancer cohorts)
| Cohort number | Cohort | Sample (n) | Fold-change | P-value |
|---|---|---|---|---|
| 1 | Notterman Colon1 | Colon adenocarcinoma (18) vs normal (18) | +7.94 | 4.94×10–5 |
| 2 | Gaspar Colon2 | Colorectal adenoma epithelia (56) vs normal (22) | +1.166 | 3.75×10–4 |
| 3 | Skrzypczak Colorectal 23 | Colon carcinoma (5) vs normal (10) | +1.373 | 9.32×10–4 |
| Colon carcinoma epithelia (5) vs normal (10) | +1.551 | 1.76×10–5 | ||
| 4 | Kaiser Colon4 | Rectal mucinous adenocarcinoma (4) vs normal (5) | +2.514 | 0.039 |
| Cecum adenocarcinoma (17) vs normal (5) | +2.049 | 0.005 | ||
| Rectosigmoid adenocarcinoma (10) vs normal (5) | +1.963 | 0.016 | ||
| Colon adenocarcinoma (41) vs normal (5) | +1.836 | 0.006 | ||
| Colon mucinous adenocarcinoma (13) vs normal (5) | +4.147 | 7.09×10–4 | ||
| Rectal adenocarcinoma (8) vs normal (5) | +2.464 | 0.015 | ||
| 5 | TCGA Colorectal | Colon mucinous adenocarcinoma (22) vs normal (22) | +2.135 | 6.42×10–4 |
| Colon adenocarcinoma (101) vs normal (22) | +1.548 | 0.002 | ||
| 6 | Hong Colorectal5 | Colorectal carcinoma (70) vs normal (12) | +2.028 | 0.011 |
| 7 | Skrzypczak Colorectal3 | Colorectal carcinoma (36) vs normal (24) | +1.399 | 0.035 |